Lamar Health is a San Francisco software company that automates the paperwork behind expensive specialty medications. Its AI-driven platform handles unified intake, insurance verification, clinical and payor requirement checks, and prior authorization submission and tracking for specialty pharmacies, infusion clinics, and home infusion pharmacies - the drugs that average around $70,000 per patient per year. Founded by Ph.D. geneticist Eesha Sharma and backed by Y Combinator (W21), Lamar aims to get patients on therapy in days instead of weeks without forcing providers to add headcount.
Eesha Sharma is the founder and CEO of Lamar Health, a Y Combinator-backed (W21) startup that uses AI to automate the mountain of paperwork standing between patients and high-cost specialty drugs. A genetics PhD from the University of Toronto and former Stanford postdoc, she traded antisense-oligonucleotide research for the unglamorous fight against prior-authorization bureaucracy after watching a family member endure years of misdiagnosis. Lamar Health now serves specialty pharmacies, infusion clinics and hospitals, automating prior auths, document review and EHR connectivity for medications that average roughly $70,000 a year per patient.